dobutamine has been researched along with Chronic Illness in 134 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (13.43) | 18.7374 |
| 1990's | 56 (41.79) | 18.2507 |
| 2000's | 43 (32.09) | 29.6817 |
| 2010's | 16 (11.94) | 24.3611 |
| 2020's | 1 (0.75) | 2.80 |
| Authors | Studies |
|---|---|
| Gyoda, Y; Kawauchi, J; Oikawa, Y; Sakuma, E; Watanabe, J | 1 |
| Alaa, M; Leite, S; Leite-Moreira, AF; Lopes, L; Lourenço, AP; Oliveira-Pinto, J; Tavares-Silva, M | 1 |
| Butterick, TA; Cabrera, JA; Duffy, CM; Holley, CT; Kelly, RF; Lindsey, ME; Long, EK; McFalls, EO; Ward, HB | 1 |
| Glaveckaite, S; Laucevicius, A; Palionis, D; Puronaite, R; Serpytis, P; Valeviciene, N | 1 |
| Al-Hesayen, A; Cherney, DZ; Floras, JS; Gilbert, C; Mak, S; Parker, AB; Parker, JD | 1 |
| Brugaletta, S; Comerci, G; Di Giannuario, G; Forni, F; Lombardo, A; Loperfido, F; Lotrionte, M; Marchese, N; Natali, R; Pisanello, C; Savino, M; Vigna, C | 1 |
| Anastasiou-Nana, M; Dimopoulos, S; Gerovasili, V; Kaldara, E; Kourtidou, S; Nanas, J; Nanas, S; Pierrakos, C; Roussos, C; Sarafoglou, S; Venetsanakos, J | 1 |
| Bonios, M; Drakos, SG; Kaldara, E; Kanakakis, JV; Katsaros, F; Nanas, JN; Nanas, S; Pantsios, C | 1 |
| Anadiotis, AV; Lerakis, S; McLean, DS | 1 |
| D'Amico, R; Di Girolamo, A; Ferraresi, S; Fiocchi, F; Ligabue, G; Modena, MG; Rossi, R; Sgura, F; Torricelli, P | 1 |
| Barbosa, MM; Esteves, WA; Fenelon, LM; Freire, CM; Nunes, Mdo C; Reis, G | 1 |
| Klopsch, C; Liebold, A; Niefeldt, S; Sandica, E; Steinhoff, G; Vollmar, B; Yerebakan, C; Zeisig, V | 1 |
| Bax, JJ; Bleeker, SE; de Roos, A; Doornbos, J; Kaandorp, TA; Lamb, HJ; Poldermans, D; van der Wall, EE; Viergever, EP | 1 |
| Bensch, R; Berghoefer, G; Kraemer, J; Mut, H; Rudolph, A; Scheiner, S; Schimke, I; Schulz, O; Schulz-Menger, J | 1 |
| Chesler, NC; Hacker, TA; Tabima, DM | 1 |
| Jameel, MN; Li, Q; Mansoor, A; Swingen, C; Xiong, Q; Zhang, J | 1 |
| Anastasiou-Nana, M; Bistola, V; Ikonomidis, I; Papadopoulos, C; Paraskevaidis, IA; Parissis, J; Stassinos, V | 1 |
| Cheng, XW; Funahashi, H; Hirashiki, A; Inden, Y; Izawa, H; Murohara, T; Nomura, M | 1 |
| Arai, AE; Schwitter, J | 1 |
| Coulden, RA; Grundy, BJ; Khoo, JP; McCann, GP; Sonnex, EP; Steadman, CD | 1 |
| Garcia, MJ; Gonzalez, W; Romero, J; Xue, X | 1 |
| Amir, O; Zafrir, B | 1 |
| Andersen, MJ; Egstrup, M; Gustafsson, I; Kistorp, CN; Møller, JE; Schou, M; Tuxen, CD | 1 |
| Blackburn, B; Chandler, MP; Morita, H; Roth, BA; Sabbah, HN; Stanley, WC; Suzuki, G; Wolff, A | 1 |
| Reek, S | 1 |
| Bristow, MR; D'Aloia, A; Dei Cas, L; Metra, M; Muneretto, C; Nodari, S; Robertson, AD | 1 |
| Corbly, AK; Gill, RM; Jones, BD; Shen, W; Steinberg, MI; Zhang, JP | 1 |
| Cerný, J; Frélich, M; Groch, L; Hude, P; Krejcí, J; Meluzín, J; Panovský, R; Rambousková, L; Spinarová, L; Stetka, F; Toman, J | 1 |
| Bijnens, B; Claus, P; D'hooge, J; De Scheerder, I; Dommke, C; Maes, A; Mertens, P; Sutherland, GR; Van de Werf, F; Verbeken, E; Weidemann, F | 1 |
| Andersson, B; Bollano, E; Hjalmarson, A; Täng, MS; Waagstein, F | 1 |
| Boldt, J; Kirchner, J; Lehmann, A | 1 |
| Campana, C; Constantin, C; Fontana, A; Ghio, S; Klersy, C; Raineri, C; Tavazzi, L | 1 |
| Bigi, R; Borges, AC; Cortigiani, L; Palagi, C; Pasanisi, E; Picano, E; Rossini, R; Sicari, R; Varga, A | 1 |
| Bagger, JP; Hall, RJ; Koutroulis, G; Nihoyannopoulos, P | 1 |
| Lekx, KS; Prato, FS; Sykes, J; Wisenberg, G | 1 |
| Fronza, J; Greene, R; Horvath, KA; Mouli, SK; Robert, ES | 1 |
| Papalia, U; Puddu, PE; Schiariti, M; Usta, C | 1 |
| Krenz, M; Robbins, J | 1 |
| Alexopoulos, GP; Anastasiou-Nana, MI; Kanakakis, J; Nanas, JN; Nanas, SN; Ntalianis, A; Papazoglou, P; Terrovitis, JV; Tsagalou, EP; Tsolakis, E | 1 |
| Castillo-Moreno, JA; Florenciano-Sánchez, R; Molina-Laborda, E; Ortega-Bernal, J; Ramos-Martín, JL | 1 |
| Adamopoulos, S; Farmakis, D; Filippatos, GS; Gheorghiade, M; Iliodromitis, EK; Karatzas, D; Kremastinos, DT; Paraskevaidis, I; Parissis, JT; Tsiapras, D | 1 |
| Kajimoto, K; Kawana, M; Watanabe, H | 1 |
| Roberts, R | 1 |
| Pasque, MK; Pellom, GL; Peyton, RB; Spray, TL; Van Trigt, P; Wechsler, AS | 1 |
| Gunnar, RM | 1 |
| Frishman, WH; Klein, NA; LeJemtel, TH; Siskind, SJ; Sonnenblick, EH | 1 |
| Biadi, O; Landoni, C; Lucignani, G; Mariani, M; Mariani, MA; Mengozzi, G; Palagi, C; Paolini, G; Vanoli, G; Zuccari, M | 1 |
| Adamopoulos, S; Bernardi, L; Coats, AJ; Piepoli, M; Sleight, P | 1 |
| Furukawa, T; Haque, T; Kinoshita, M; Takahashi, M | 1 |
| Ling, LH; Pellikka, PA; Tei, C | 1 |
| Hamato, N; Kawasaki, T; Kimura, T; Moriyasu, F; Okuma, M; Someda, H | 1 |
| Berger, R; Globits, S; Heinz, G; Kreiner, G; Pacher, R; Presch, I; Radosztics, S; Rödler, S; Weber, H; Wutte, M | 1 |
| Bonijoly, S; Favre, E; Marcon, JL | 1 |
| Gheorghiade, M; Sy, J; Vitarelli, A | 1 |
| Alam, M; Goldstein, S; Kono, T; Rosman, H; Sabbah, HN; Shimoyama, H | 1 |
| Creswell, LL; Dávila-Román, VG; Pérez, JE; Rosenbloom, M | 1 |
| Kajimura, K; Kimura, T; Mori, K; Moriyasu, F; Okuma, M; Ozawa, K | 1 |
| Bain, RJ; Davies, MK; Lawson, N; Qiang, FX; Townend, JN; Virk, SJ | 1 |
| van der Giessen, WJ; van Woerkens, LJ; Verdouw, PD | 1 |
| Izumi, T; Kodama, M; Koyama, S; Shibata, A | 1 |
| Bol, A; Gerber, BL; Labar, D; Melin, JA; Michel, C; Vanoverschelde, JL; Wijns, W | 1 |
| Adamopoulos, S; Bemardi, L; Coats, AJ; Piepoli, M; Ponikowski, P; Radaelli, A; Sleight, P | 1 |
| Betocchi, S; Chiariello, M; Crisci, T; Indolfi, C; Pace, L; Perrone-Filardi, P; Piscione, F; Prastaro, M; Salvatore, M; Soricelli, A; Squame, F | 1 |
| Assmann, G; Breithardt, G; Brisse, B; Deng, MC; Erren, M; Lütgen, A; Scheld, HH; Schmitz, W; Zimmermann, P | 1 |
| Berger, R; Daneschvar, H; Frey, B; Grimm, M; Hülsmann, M; Laufer, G; Pacher, R; Rödler, S; Siegel, A; Stanek, B | 1 |
| Bax, JJ; Cornel, JH; Elhendy, A; Fioretti, PM; Reijs, AE | 1 |
| Marwick, TH | 1 |
| Curiel, RV; Laurienzo, JM; Panza, JA; Unger, EF | 1 |
| Douglas, PS; Lualdi, JC | 1 |
| Chen, C | 1 |
| Bax, JJ; Boersma, E; Cornel, JH; Fioretti, PM; Visser, FC; Wijns, W | 1 |
| Capomolla, S; Cobelli, F; Febo, O; Maestri, R; Opasich, C; Pozzoli, M; Riccardi, G; Salvucci, F; Sisti, M; Tavazzi, L | 1 |
| D'Hondt, AM; Melin, JA; Pasquet, A; Vanoverschelde, JL | 1 |
| Genma, Y; Ogawa, S; Yamamoto, M; Zhang, J | 1 |
| Bax, JJ; Boersma, E; Cornel, JH; Elhendy, A; Fioretti, PM; Geleijnse, ML; Kimman, GJ; Maat, AP; Rambaldi, R | 1 |
| Baer, FM; Erdmann, E; Schicha, H; Schneider, CA; Sechtem, U; Theissen, P; Voth, E | 1 |
| Bonser, RS; Camici, PG; Lorenzoni, R; Ordoubadi, F; Pagano, D; Townend, JN | 1 |
| Bental, T; Elis, A; Kimchi, O; Lishner, M; Ravid, M | 1 |
| Barletta, G; Del Bene, R; Fantini, F; Gallini, C; Lo Sapio, P | 1 |
| Cherng, WJ; Chung, SY; Hung, MJ; Wang, CH | 1 |
| Dionisopoulos, PN; Knickelbine, TA; Sagar, KB; Schuchard, T; Smart, SC | 1 |
| Acquatella, H; Condado, JA; Pérez, JE; Sánchez, I | 1 |
| Antecol, D; Chan, KL; Kim, HH; Tam, JW; Yvorchuk, KJ | 1 |
| Junger, E; Liziczai, I; Nagy, L; Tarján, J | 1 |
| Herth, F; Schulz, V; Wiebel, M | 1 |
| Bax, JJ; Boersma, E; Cornel, JH; Elhendy, A; Fioretti, PM; Poldermans, D; Rambaldi, R; Roelandt, JR | 1 |
| Young, JB | 1 |
| Dobbeleir, A; Hambye, AS; Vervaet, A | 1 |
| Alessandrini, RS; Bonow, RO; Chaudhry, FA; Parker, MA; Tauke, JT; Vardi, G | 1 |
| Vanoverschelde, JL | 1 |
| Furukawa, T; Haque, T; Kinoshita, M; Maeda, K; Takahashi, M | 1 |
| Borzak, S; Goldstein, S; Mishima, T; Sabbah, HN; Steinberg, MI; Tanimura, M | 1 |
| Armstrong, WF; Avelar, E; Grossman, PM; Nicklas, JM; Oral, H; Sachdev, V; Sherman, HL | 1 |
| De Rito, V; Fanelli, R; Forleo, G; Lombardo, A; Loperfido, F; Natali, R; Perna, GP; Russo, A; Stanislao, M; Vigna, C | 1 |
| Coleman, RE; DeGrado, TR; Donovan, CL; Hughes, GC; Kypson, AP; Landolfo, KP; Lowe, JE; St Louis, JD; Steenbergen, C; Yin, B | 1 |
| Baer, FM; Crnac, J; Deutsch, HJ; Erdmann, E; Schicha, H; Schmidt, M; Sechtem, U; Theissen, P | 1 |
| Chiang, FT; Huang, PJ; Hwang, JJ; Lin, LC; Tseng, CD; Yen, RF | 1 |
| Bax, JJ; Cornel, JH; Elhendy, A; Roelandt, JR; van Domburg, RT | 1 |
| Borim, AA; Brienzi, SL; Castillo, VG; de Oliveira, GG; Lobo, SM; Palchetti, JC; Polachini, CA; Salgado, PF | 1 |
| Muro, T; Ota, T; Takeuchi, K; Teragaki, M; Watanabe, H; Yoshikawa, J | 1 |
| Chiariello, M; Crisci, T; Della Morte, AM; Dellegrottaglie, S; Pace, L; Perrone-Filardi, P; Piscione, F; Ponticelli, MP; Prastaro, M; Salvatore, M; Storto, G | 1 |
| Casanova, JM; Chávez, PY; Espinola-Zavaleta, N; Gómez-Núñez, N; Keirns, C; Roldán, FJ; Romero-Cárdenas, A; Sahagun-Sánchez, G; Vargas-Barrón, J | 1 |
| Bin, JP; Goodman, NC; Kaul, S; Le, E; Pelberg, RA; Spotnitz, WD | 1 |
| Baan, J; Helbing, WA; Leeuwenburgh, BP; Schoof, PH; Steendijk, P | 1 |
| Cumberledge, B; Haaverstad, R; Irvine, T; Karvounis, H; Kenny, A; Louridas, G; Parharidis, G; Zaglavara, T | 1 |
| Gorski, LA | 1 |
| Leoncini, M; Sciagrà, R | 1 |
| Dart, J; Marwick, TH; Najos, O; Yuda, S | 1 |
| Armstrong, PW | 1 |
| Benvenisty, AI; Hoffman, BF; Malm, JR; Rose, EA; Spotnitz, HM | 1 |
| Berkowitz, C; Croke, RP; Gunnar, RM; Jacobs, WR; Loeb, HS; McKeever, L | 1 |
| Hutton, I; Platt, MR; Templeton, GH; Watson, JT; Willerson, JT | 1 |
| Benvenuti, C; Bohuon, C; Carville, C; Castaigne, A; Comoy, E; Dubois-Randé, JL; Hittinger, L; Macquin-Mavier, I; Merlet, P | 1 |
| Cleland, JG; Frost, G; Good, J; Oakley, CM | 1 |
| Bossan, P; Drici, M; Ferrari, E; Gibelin, P; Morand, P | 1 |
| Annane, D; Bellissant, E; Depret, J; Richard, C; Teboul, JL; Thuillez, C | 1 |
| Alfieri, O; Gargano, M; La Canna, G; Visioli, O | 1 |
| Bolukoglu, H; Eggleston, AM; Liedtke, AJ; Nellis, SH; Renstrom, B; Subramanian, R | 1 |
| Baumann, G; Gerzer, R; Stangl, K; Weil, J | 1 |
| Paccagnella, A; Simini, G; Valfré, C | 1 |
| Guy, S; Silke, B | 1 |
| Adamopoulos, S; Coats, AJ | 1 |
| Bounhoure, JP; Edouard, P; Fauvel, JM; Fourcade, J; Galinier, M; Massabuau, P; Puel, J; Rochiccioli, JP | 1 |
| Demedts, M; Van den Brande, P; Van Mieghem, W | 1 |
| Baumann, G; Ningel, K; Permanetter, B | 1 |
| Gilfrich, HJ; Römer, A; Witzke-Gross, J | 1 |
| Kanda, H | 1 |
| Colucci, WS | 1 |
| Crawford, MV; Schactman, M | 1 |
| Hattori, R; Kawai, C; Sakaguchi, K; Susawa, T; Takatsu, Y; Yui, N; Yui, Y | 1 |
| Baumann, G; Gutting, M; Klein, G; Ningel, K; Pfafferott, C | 1 |
| Kanda, H; Nakamura, K; Ohta, T; Okada, M; Satoh, H | 1 |
| Applefeld, MM; Grove, WR; Newman, KA; Reed, WP; Roffman, DS; Sutton, FJ; Talesnick, BS | 1 |
| Applefeld, MM | 1 |
18 review(s) available for dobutamine and Chronic Illness
| Article | Year |
|---|---|
[The Role of Pharmacists in Home Medical Care of Patients with Heart Failure].
Topics: Catecholamines; Chronic Disease; Dobutamine; Furosemide; Heart Failure; Home Care Services; Humans; Injections; Patient Care Team; Pharmacists; Professional Role | 2020 |
Role of echocardiography in the assessment of myocardial viability.
Topics: Cardiology; Chronic Disease; Dobutamine; Echocardiography; Electrocardiography; Humans; Myocardial Infarction; Myocardial Stunning; Myocardium; Perfusion; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Ultrasonography, Doppler | 2009 |
Assessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonance.
Topics: Cardiotonic Agents; Chronic Disease; Contrast Media; Coronary Artery Disease; Death, Sudden, Cardiac; Diagnosis, Differential; Dobutamine; Feasibility Studies; Heart Failure; Humans; Magnetic Resonance Angiography; Myocardial Infarction; Myocardial Ischemia; Patient Safety; Prognosis | 2011 |
CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective trials.
Topics: Aged; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Contrast Media; Coronary Disease; Dobutamine; Evidence-Based Medicine; Female; Heart Ventricles; Humans; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Contraction; Myocardial Stunning; Myocardium; Predictive Value of Tests; Prognosis; Prospective Studies; Sensitivity and Specificity; Tissue Survival; Ventricular Dysfunction, Left; Ventricular Function, Left | 2012 |
Beta blocker therapy, decompensated heart failure, and inotropic interactions: current perspectives.
Topics: Acute Disease; Adrenergic beta-Antagonists; Cardiotonic Agents; Chronic Disease; Dobutamine; Drug Interactions; Drug Therapy, Combination; Heart Failure; Hospitalization; Humans; Hydrazones; Phosphodiesterase Inhibitors; Practice Guidelines as Topic; Pyridazines; Simendan | 2012 |
The role of Ca++-sensitizers for the treatment of heart failure.
Topics: Calcium; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Dobutamine; Heart Failure; Hemodynamics; Humans; Hydrazones; Myocardial Ischemia; Pyridazines; Simendan | 2003 |
[Combination therapy with PDE III inhibitor for heart failure].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Chronic Disease; Clinical Trials as Topic; Cyclic Nucleotide Phosphodiesterases, Type 3; Dobutamine; Drug Therapy, Combination; Heart Failure; Humans; Hydrazones; Milrinone; Phosphodiesterase Inhibitors; Pyridazines; Simendan | 2007 |
The role of diuretics and inotropic therapy in failure associated with myocardial infarction.
Topics: Acute Disease; Blood Pressure; Cardiac Complexes, Premature; Cardiotonic Agents; Chronic Disease; Digoxin; Diuretics; Dobutamine; Heart Failure; Hemodynamics; Humans; Isoproterenol; Myocardial Infarction | 1984 |
The role of vasodilating agents in the treatment of chronic heart failure.
Topics: Cardiac Output; Chronic Disease; Dobutamine; Heart Failure; Humans; Muscle Contraction; Nitroprusside; Phentolamine; Prazosin; Pulmonary Edema; Vascular Resistance; Vasodilator Agents | 1980 |
Assessment of myocardial viability in chronic left ventricular dysfunction.
Topics: Chronic Disease; Deoxyglucose; Dobutamine; Echocardiography; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Magnetic Resonance Imaging; Myocardial Stunning; Myocardium; Nitroglycerin; Thallium Radioisotopes; Tissue Survival; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 1995 |
[Intermittent infusions of dobutamine in the treatment of chronic cardiac failure in the terminal stage].
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Dobutamine; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged | 1993 |
Nicardipine in heart failure: distinguishing its acute beneficial from its chronic effects.
Topics: Acute Disease; Calcium Channel Blockers; Chronic Disease; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Nicardipine; Renin-Angiotensin System; Time Factors | 1993 |
Use of stress echocardiography for the prognostic assessment of patients with stable chronic coronary artery disease.
Topics: Cardiotonic Agents; Chronic Disease; Coronary Disease; Dipyridamole; Dobutamine; Echocardiography; Exercise Test; Humans; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; Vasodilator Agents | 1997 |
Echocardiography for the assessment of myocardial viability.
Topics: Adrenergic beta-Agonists; Chronic Disease; Coronary Disease; Dipyridamole; Dobutamine; Echocardiography; Humans; Myocardial Infarction; Myocardial Revascularization; Myocardium; Patient Selection; Prognosis; Radiopharmaceuticals; Safety; Thallium Radioisotopes; Tissue Survival; Tomography, Emission-Computed; Vasodilator Agents; Ventricular Function, Left | 1997 |
Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data.
Topics: Chronic Disease; Confidence Intervals; Coronary Disease; Dobutamine; Echocardiography; Female; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Revascularization; Predictive Value of Tests; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1997 |
Low dose dobutamine echocardiography in the assessment of contractile reserve to predict the outcome of valve replacement for chronic aortic regurgitation.
Topics: Adult; Aged; Aortic Valve; Aortic Valve Insufficiency; Chronic Disease; Contrast Media; Dobutamine; Dose-Response Relationship, Drug; Echocardiography; Female; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Myocardial Contraction; Predictive Value of Tests | 1999 |
[Role of perfusion myocardial scintigraphy with gated SPECT technique in the diagnostic and prognostic evaluation of patients with chronic coronary disease].
Topics: Cardiotonic Agents; Chronic Disease; Coronary Disease; Death, Sudden, Cardiac; Dobutamine; Humans; Hypertrophy, Left Ventricular; Myocardial Contraction; Myocardial Infarction; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2002 |
[Treatment of chronic heart insufficiency with dobutamine. Value and limitations].
Topics: Chronic Disease; Dobutamine; Drug Tolerance; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous | 1992 |
18 trial(s) available for dobutamine and Chronic Illness
| Article | Year |
|---|---|
Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Carbazoles; Cardiotonic Agents; Carvedilol; Chronic Disease; Dobutamine; Drug Interactions; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Radionuclide Angiography; Severity of Illness Index; Time Factors; Treatment Outcome | 2002 |
Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiotonic Agents; Carvedilol; Chronic Disease; Cross-Over Studies; Dobutamine; Dopamine; Echocardiography, Stress; Heart Failure; Humans; Metoprolol; Middle Aged; Propanolamines; Single-Blind Method; Treatment Outcome | 2003 |
Enoximone echocardiography: a novel test to evaluate left ventricular contractile reserve in patients with heart failure on chronic beta-blocker therapy.
Topics: Adrenergic beta-Antagonists; Chronic Disease; Dobutamine; Echocardiography; Enoximone; Exercise Test; Female; Heart Failure; Humans; Image Enhancement; Male; Middle Aged; Myocardial Infarction; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Vasodilator Agents; Ventricular Dysfunction, Left | 2003 |
Dobutamine effects on spontaneous variability of ventricular arrhythmias in patients with severe chronic heart failure: the Italian Multicenter Study.
Topics: Aged; Chronic Disease; Confidence Intervals; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Probability; Prospective Studies; Reference Values; Risk Assessment; Severity of Illness Index; Survival Analysis; Tachycardia, Ventricular; Treatment Outcome | 2004 |
Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
Topics: Aged; Apoptosis; Cardiotonic Agents; Chronic Disease; Dobutamine; Echocardiography; Fas Ligand Protein; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Interleukin-6; Male; Membrane Glycoproteins; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Pulmonary Wedge Pressure; Pyridazines; Simendan; Stroke Volume; Treatment Outcome; Tumor Necrosis Factor-alpha; Tumor Necrosis Factors | 2006 |
Sympathetic stimulations by exercise-stress testing and by dobutamine infusion induce similar changes in heart rate variability in patients with chronic heart failure.
Topics: Aged; Blood Pressure; Chronic Disease; Cross-Over Studies; Dobutamine; Exercise; Exercise Test; Heart Failure; Heart Rate; Humans; Middle Aged; Reproducibility of Results; Sympathetic Nervous System | 1995 |
Beneficial hemodynamic effects of prostaglandin E1 infusion in catecholamine-dependent heart failure: results of a prospective, randomized, controlled study.
Topics: Alprostadil; Analysis of Variance; Chronic Disease; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Single-Blind Method; Time Factors | 1994 |
Interleukin-6 correlates with hemodynamic impairment during dobutamine administration in chronic heart failure.
Topics: Adult; Chronic Disease; Dobutamine; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Interleukin-6; Male; Middle Aged; Pilot Projects; Prognosis; Sensitivity and Specificity; Severity of Illness Index; Stroke Volume; Vascular Resistance | 1996 |
The magnitude of inotropic reserve is unrelated to basal systolic function or wall thickness in patients with chronic ischemic left ventricular dysfunction.
Topics: Aged; Cardiotonic Agents; Chronic Disease; Coronary Disease; Dobutamine; Echocardiography, Transesophageal; Female; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Systole; Ventricular Dysfunction, Left | 1997 |
Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study.
Topics: Adrenergic beta-Agonists; Aged; Cardiotonic Agents; Chronic Disease; Dobutamine; Double-Blind Method; Drug Administration Schedule; Female; Heart Failure; Humans; Injections, Intravenous; Male; Myocardial Ischemia; Severity of Illness Index; Survival Analysis; Treatment Outcome | 1998 |
Effect of coronary artery bypass surgery on myocardial perfusion and ejection fraction response to inotropic stimulation in patients without improvement in resting ejection fraction.
Topics: Cardiotonic Agents; Chronic Disease; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Dobutamine; Female; Humans; Male; Middle Aged; Radionuclide Ventriculography; Stroke Volume; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2000 |
Effects of maximizing oxygen delivery on morbidity and mortality in high-risk surgical patients.
Topics: Aged; Aged, 80 and over; Cardiotonic Agents; Chronic Disease; Dobutamine; Elective Surgical Procedures; Hemodynamics; Humans; Intraoperative Care; Middle Aged; Morbidity; Multiple Organ Failure; Oxygen Consumption; Postoperative Care; Prospective Studies; Survival Analysis; Time Factors; Treatment Outcome | 2000 |
Prediction of improvement in global left ventricular function in patients with chronic coronary artery disease and impaired left ventricular function: rest thallium-201 SPET versus low-dose dobutamine echocardiography.
Topics: Adrenergic beta-Agonists; Aged; Chronic Disease; Coronary Disease; Dobutamine; Echocardiography; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Stroke Volume; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2000 |
The renal effects of dopamine and dobutamine in stable chronic heart failure.
Topics: Aged; Chronic Disease; Diuresis; Dobutamine; Dopamine; Drug Interactions; Drug Therapy, Combination; Furosemide; Heart Failure; Humans; Kidney; Male; Middle Aged; Single-Blind Method | 1992 |
[Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
Topics: Adult; Aged; Cardiac Output, Low; Cardiotonic Agents; Chronic Disease; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged | 1990 |
Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure.
Topics: Adult; Blood Pressure; Cardiac Output; Cardiomyopathy, Dilated; Cardiotonic Agents; Chronic Disease; Dobutamine; Heart Failure; Heart Rate; Hemodynamics; Humans; Middle Aged; Myocardial Contraction; Nitroprusside; Pulmonary Artery; Pulmonary Wedge Pressure; Pyridazines; Receptors, Adrenergic, beta; Stroke Volume; Time Factors; Vascular Resistance | 1989 |
Hemodynamic effect of oral TA-064 after dobutamine in congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Cardiac Output, Low; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Dobutamine; Ethanolamines; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Time Factors | 1987 |
Comparison of acute haemodynamic effects of dopexamine hydrochloride, dobutamine and sodium nitroprusside in chronic heart failure.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Chronic Disease; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Ferricyanides; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Nitroprusside; Random Allocation; Stimulation, Chemical | 1988 |
98 other study(ies) available for dobutamine and Chronic Illness
| Article | Year |
|---|---|
Dose-Response Head-to-Head Comparison of Inodilators Dobutamine, Milrinone, and Levosimendan in Chronic Experimental Pulmonary Hypertension.
Topics: Animals; Calcium; Chronic Disease; Dobutamine; Dose-Response Relationship, Drug; Hemodynamics; Hydrazones; Hypertension, Pulmonary; Male; Milrinone; Pyridazines; Rats; Rats, Wistar; Simendan | 2017 |
Expression of uncoupling protein-2 remains increased within hibernating myocardium despite successful coronary artery bypass grafting at 4 wk post-revascularization.
Topics: Animals; Cardiac Imaging Techniques; Cardiotonic Agents; Cell Respiration; Chronic Disease; Coronary Artery Bypass; Coronary Circulation; Disease Models, Animal; Dobutamine; Echocardiography, Doppler; Heart Failure; Ion Channels; Mitochondria; Mitochondrial Proteins; Myocardial Stunning; Oxidative Stress; Swine; Tomography, X-Ray Computed; Uncoupling Protein 2 | 2015 |
Prediction of long-term segmental and global functional recovery of hibernating myocardium after revascularisation based on low dose dobutamine and late gadolinium enhancement cardiovascular magnetic resonance.
Topics: Adrenergic beta-1 Receptor Agonists; Aged; Chronic Disease; Contrast Media; Dobutamine; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Contraction; Myocardial Revascularization; Myocardial Stunning; Predictive Value of Tests; Prospective Studies; Recovery of Function; Stroke Volume; Time Factors; Tissue Survival; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2014 |
Hemodynamic and neurochemical determinates of renal function in chronic heart failure.
Topics: Aged; Aged, 80 and over; Arterial Pressure; Atrial Function, Right; Atrial Pressure; Cardiac Catheterization; Case-Control Studies; Chronic Disease; Dobutamine; Female; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Kidney; Male; Middle Aged; Models, Cardiovascular; Nitroprusside; Renal Plasma Flow; Sympathetic Nervous System; Sympathomimetics; Vasodilator Agents; Ventricular Function, Left | 2016 |
Prediction of functional capacity by low-dose dobutamine stress echocardiography in chronic heart failure.
Topics: Adrenergic beta-Agonists; Aged; Chronic Disease; Dobutamine; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Myocardial Contraction; Natriuretic Peptide, Brain; Oxygen Consumption; Peptide Fragments; Prospective Studies; Respiratory Function Tests; Ventricular Dysfunction, Left | 2008 |
Inotropic agents improve the peripheral microcirculation of patients with end-stage chronic heart failure.
Topics: Adrenergic beta-Agonists; Brachial Artery; Cardiotonic Agents; Case-Control Studies; Chronic Disease; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Male; Microcirculation; Middle Aged; Muscle, Skeletal; Myocardial Reperfusion; Oxygen Consumption; Prognosis; Prospective Studies; Pyridazines; Simendan; Spectroscopy, Near-Infrared; Vasodilator Agents | 2008 |
Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Cardiotonic Agents; Chronic Disease; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyridazines; Simendan; Survival Rate; Treatment Outcome | 2009 |
Chronic total coronary occlusion in patients with intermediate viability: value of low-dose dobutamine and contrast-enhanced 3-T MRI in predicting functional recovery in patients undergoing percutaneous revascularisation with drug-eluting stent.
Topics: Aged; Cardiotonic Agents; Chronic Disease; Contrast Media; Coronary Stenosis; Dobutamine; Drug-Eluting Stents; Female; Heterocyclic Compounds; Humans; Linear Models; Magnetic Resonance Imaging; Male; Myocardial Revascularization; Organometallic Compounds; Predictive Value of Tests; Recovery of Function; Treatment Outcome | 2009 |
Dobutamine-stress echocardiography in asymptomatic patients with aortic regurgitation.
Topics: Adult; Aortic Valve Insufficiency; Cardiotonic Agents; Chronic Disease; Dobutamine; Echocardiography, Doppler; Echocardiography, Stress; Female; Follow-Up Studies; Humans; Male; Radionuclide Angiography; Ventricular Dysfunction, Left; Ventricular Function, Left | 2009 |
Acute and chronic response of the right ventricle to surgically induced pressure and volume overload--an analysis of pressure-volume relations.
Topics: Acute Disease; Animals; Cardiac Catheterization; Cardiotonic Agents; Chronic Disease; Constriction; Disease Models, Animal; Dobutamine; Female; Heart Defects, Congenital; Male; Myocardial Contraction; Pericardiectomy; Pulmonary Artery; Sheep; Sternotomy; Stroke Volume; Thoracotomy; Time Factors; Ventricular Dysfunction, Right; Ventricular Function, Right; Ventricular Outflow Obstruction; Ventricular Pressure | 2010 |
Relation between regional and global systolic function in patients with ischemic cardiomyopathy after beta-blocker therapy or revascularization.
Topics: Adrenergic beta-Antagonists; Aged; Angioplasty, Balloon, Coronary; Cardiomyopathies; Chronic Disease; Coronary Artery Bypass; Dobutamine; Female; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Ischemia; Stroke Volume; Systole; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2010 |
Influence of acute and chronic myocardial loading conditions, function, structural changes and extracardiac factors on NT-proBNP in asymptomatic patients with preserved ejection fraction.
Topics: Acute Disease; Aged; Biomarkers; Chronic Disease; Dobutamine; Exercise Test; Female; Fibrosis; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Stroke Volume; Vasodilator Agents; Ventricular Dysfunction, Left | 2011 |
Measuring right ventricular function in the normal and hypertensive mouse hearts using admittance-derived pressure-volume loops.
Topics: Adrenergic beta-1 Receptor Agonists; Animals; Blood Pressure; Cardiac Catheterization; Cardiac Output; Chronic Disease; Disease Models, Animal; Dobutamine; Feasibility Studies; Heart Rate; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Infusions, Intravenous; Male; Mice; Mice, Inbred C57BL; Predictive Value of Tests; Time Factors; Ventricular Dysfunction, Right; Ventricular Function, Right; Ventricular Pressure | 2010 |
Long-term preservation of myocardial energetic in chronic hibernating myocardium.
Topics: Animals; Cardiotonic Agents; Chronic Disease; Coronary Vessels; Dobutamine; Dopamine; Female; Heart; Myocardial Ischemia; Myocardial Stunning; Myocardium; Swine; Swine, Miniature | 2011 |
Dobutamine-induced changes of left atrial two-dimensional deformation predict clinical and neurohumoral improvement after levosimendan treatment in patients with acutely decompensated chronic heart failure.
Topics: Aged; Atrial Function, Left; Biomarkers; Chronic Disease; Dobutamine; Echocardiography; Echocardiography, Stress; Female; Forecasting; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Pyridazines; Simendan; Treatment Outcome | 2012 |
Altered microRNA expression associated with reduced catecholamine sensitivity in patients with chronic heart failure.
Topics: Cardiac Catheterization; Cardiomyopathy, Dilated; Catecholamines; Chronic Disease; Dobutamine; Female; Gene Expression Regulation; Heart Failure; Humans; Male; Microarray Analysis; MicroRNAs; Middle Aged; Myocardial Contraction; Myocardium; Norepinephrine; Receptors, Adrenergic; Ventricular Function | 2011 |
Stress cardiovascular MR in routine clinical practice: referral patterns, accuracy, tolerance, safety and incidental findings.
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Bundle-Branch Block; Cardiomyopathies; Cardiotonic Agents; Chest Pain; Chronic Disease; Contrast Media; Coronary Stenosis; Cysts; Dobutamine; Exercise Test; Gadolinium DTPA; Heart Neoplasms; Heart Valve Diseases; Humans; Incidental Findings; Lipoma; Liver Diseases; Magnetic Resonance Angiography; Middle Aged; Multiple Pulmonary Nodules; Referral and Consultation; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Thrombosis; Vasodilator Agents; Ventricular Dysfunction, Left | 2012 |
Haemodynamic response during low-dose dobutamine infusion in patients with chronic systolic heart failure: comparison of echocardiographic and invasive measurements.
Topics: Aged; Cardiac Catheterization; Cardiac Output; Chronic Disease; Cohort Studies; Dobutamine; Dose-Response Relationship, Drug; Echocardiography, Doppler, Pulsed; Echocardiography, Stress; Female; Heart Failure, Systolic; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Pulmonary Wedge Pressure; Reference Values; Risk Assessment; Severity of Illness Index; Stroke Volume; Ventricular Dysfunction, Left | 2013 |
Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart failure.
Topics: Acetanilides; Animals; Cardiotonic Agents; Chronic Disease; Coronary Circulation; Disease Models, Animal; Dobutamine; Dogs; Drug Administration Schedule; Fatty Acids, Nonesterified; Glucose; Heart; Heart Failure; Heart Rate; Lactic Acid; Myocardium; Oxygen Consumption; Piperazines; Ranolazine; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
[How is catecholamine therapy carried out in heart failure?].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Catecholamines; Chronic Disease; Dobutamine; Drug Therapy, Combination; Epinephrine; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Treatment Outcome | 2002 |
Combined inotropic and bradycardic effects of a sodium channel enhancer in conscious dogs with heart failure: a mechanism for improved myocardial efficiency compared with dobutamine.
Topics: Animals; Azetidines; Cardiotonic Agents; Chronic Disease; Coronary Circulation; Cyclic AMP; Dobutamine; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Heart Failure; Heart Rate; Male; Myocardial Contraction; Myocardium; Oxygen Consumption; Sodium Channel Agonists; Ventricular Function, Left | 2002 |
Prognosis of patients with chronic coronary artery disease and severe left ventricular dysfunction. The importance of myocardial viability.
Topics: Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Cardiac Surgical Procedures; Cell Survival; Chronic Disease; Coronary Artery Disease; Dobutamine; Echocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardium; Postoperative Complications; Prognosis; Severity of Illness Index; Stroke Volume; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
Defining the transmurality of a chronic myocardial infarction by ultrasonic strain-rate imaging: implications for identifying intramural viability: an experimental study.
Topics: Animals; Cell Survival; Chronic Disease; Disease Models, Animal; Dobutamine; Echocardiography; Echocardiography, Stress; Heart; Hemodynamics; Myocardial Contraction; Myocardial Infarction; Predictive Value of Tests; Stents; Stress, Mechanical; Swine; Systole; Tomography, Emission-Computed | 2003 |
Prognostic value of myocardial viability recognized by low-dose dobutamine echocardiography in chronic ischemic left ventricular dysfunction.
Topics: Cardiotonic Agents; Chronic Disease; Dobutamine; Echocardiography; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardium; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Survival Rate; Ventricular Dysfunction, Left | 2003 |
Effect of enhanced external counterpulsation on dobutamine-induced left ventricular wall motion abnormalities in severe chronic angina pectoris.
Topics: Aged; Angina Pectoris; Chronic Disease; Counterpulsation; Dobutamine; Echocardiography; Exercise Test; Female; Humans; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2004 |
The partition coefficient of Gd-DTPA reflects maintained tissue viability in a canine model of chronic significant coronary stenosis.
Topics: Adrenergic beta-Agonists; Animals; Chronic Disease; Contrast Media; Coronary Angiography; Coronary Circulation; Coronary Stenosis; Disease Models, Animal; Dobutamine; Dogs; Dose-Response Relationship, Drug; Echocardiography, Stress; Female; Follow-Up Studies; Gadolinium DTPA; Image Enhancement; Magnetic Resonance Angiography; Models, Cardiovascular; Myocardium; Stroke Volume | 2004 |
What is the optimal channel density for transmyocardial laser revascularization?
Topics: Animals; Chronic Disease; Dobutamine; Echocardiography; Heart Rate; Laser Therapy; Magnetic Resonance Imaging, Cine; Myocardial Contraction; Myocardial Ischemia; Random Allocation; Sus scrofa; Thoracotomy; Ventricular Function, Left | 2004 |
Impact of beta-myosin heavy chain expression on cardiac function during stress.
Topics: Animals; Body Weight; Cardiac Output, Low; Cardiomegaly; Cardiotonic Agents; Chronic Disease; Dobutamine; Echocardiography; Female; Heart; Heart Ventricles; Isoproterenol; Mice; Mice, Transgenic; Motor Activity; Myocardial Contraction; Myocardial Infarction; Myocardium; Myosin Heavy Chains; Organ Size; Stress, Physiological; Stroke Volume; Swimming; Time Factors; Ventricular Dysfunction, Left; Ventricular Myosins | 2004 |
Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone.
Topics: Adult; Aged; Cardiotonic Agents; Chronic Disease; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Multivariate Analysis; Pyridazines; Radionuclide Ventriculography; Risk; Simendan; Survival Rate | 2005 |
[Dobutamine stress echocardiography in patients with stable chronic angina and a low- or medium-risk on exercise testing: usefulness for assessing long-term prognosis].
Topics: Adult; Angina Pectoris; Angina, Unstable; Chronic Disease; Dobutamine; Echocardiography, Stress; Exercise Test; Female; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Prognosis; Risk Factors; Time Factors | 2005 |
The comparative effects of dopamine and dobutamine on ventricular mechanics after coronary artery bypass grafting: a pressure-dimension analysis.
Topics: Angina Pectoris; Biomechanical Phenomena; Catecholamines; Chronic Disease; Coronary Artery Bypass; Dobutamine; Dopamine; Drug Evaluation; Heart; Heart Ventricles; Humans; Myocardial Contraction; Postoperative Period; Transducers, Pressure; Ultrasonics; Ultrasonography | 1984 |
Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure.
Topics: Adolescent; Adult; Aged; Aminopyridines; Amrinone; Cardiac Output; Catecholamines; Chronic Disease; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Pulmonary Wedge Pressure; Time Factors | 1981 |
Relation between dobutamine trans-thoracic echocardiography, 99Tcm-MIBI and 18FDG uptake in chronic coronary artery disease.
Topics: Adult; Aged; Chronic Disease; Contrast Media; Coronary Disease; Deoxyglucose; Dobutamine; Echocardiography; Exercise Test; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Ventricular Dysfunction, Left | 1995 |
Identification of hibernating myocardium by dobutamine stress echocardiography: comparison with thallium-201 reinjection imaging.
Topics: Adult; Aged; Chronic Disease; Coronary Disease; Dobutamine; Echocardiography; Exercise Test; Female; Follow-Up Studies; Heart; Humans; Male; Middle Aged; Myocardial Ischemia; Prognosis; Prospective Studies; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed | 1995 |
Effects of dobutamine on hepatosplanchnic hemodynamics in patients with chronic liver disease.
Topics: Aged; Blood Flow Velocity; Catheterization, Peripheral; Chronic Disease; Dobutamine; Female; Hepatic Veins; Hepatitis; Humans; Infusions, Intravenous; Liver; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Portal System; Splanchnic Circulation; Ultrasonography, Doppler, Duplex | 1994 |
Divergent effects of intravenous dobutamine and nitroprusside on left atrial contribution to ventricular filling in dogs with chronic heart failure.
Topics: Animals; Chronic Disease; Coronary Angiography; Diastole; Dobutamine; Dogs; Echocardiography, Doppler; Heart Atria; Heart Failure; Hemodynamics; Infusions, Intravenous; Nitroprusside; Ventricular Function, Left | 1994 |
Myocardial contractile state in dogs with chronic mitral regurgitation: echocardiographic approach to the peak systolic pressure/end-systolic area relationship.
Topics: Animals; Chronic Disease; Dobutamine; Dogs; Echocardiography; Methoxamine; Mitral Valve Insufficiency; Myocardial Contraction; Nitroglycerin; Stimulation, Chemical; Stroke Volume; Systole; Ventricular Function, Left | 1993 |
Effect of dobutamine on the arterial ketone body ratio and portal blood flow velocity in cirrhosis.
Topics: Blood Flow Velocity; Chronic Disease; Dobutamine; Female; Hepatitis; Humans; Ketone Bodies; Liver; Liver Cirrhosis; Male; Middle Aged; Portal System; Ultrasonography | 1993 |
Lymphocyte beta adrenoceptor upregulation and improved cardiac response to adrenergic stimulation following converting enzyme inhibition in congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Dobutamine; Exercise; Female; Heart Failure; Hemodynamics; Humans; Isoquinolines; Lymphocytes; Male; Middle Aged; Quinapril; Receptors, Adrenergic, beta; Tetrahydroisoquinolines; Up-Regulation | 1993 |
Cardiovascular effects of dopamine and dobutamine in conscious pigs with chronic heart failure.
Topics: Animals; Chronic Disease; Dobutamine; Dopamine; Female; Heart Failure; Hemodynamics; Male; Prospective Studies; Swine; Ventricular Function, Left | 1993 |
Experimental rat model representing both acute and chronic heart failure related to autoimmune myocarditis.
Topics: Acute Disease; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Autoimmune Diseases; Blood Pressure; Body Weight; Chronic Disease; Disease Models, Animal; Dobutamine; Electrocardiography; Heart; Heart Failure; Male; Myocarditis; Myocardium; Myosins; Organ Size; Rats; Rats, Inbred Lew; Staining and Labeling; Ventricular Function, Left | 1995 |
Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation.
Topics: Adult; Aged; Ammonia; Carbon Isotopes; Chronic Disease; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Deoxyglucose; Dobutamine; Echocardiography; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Heart; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardium; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 1996 |
Reproducibility of heart rate variability indices during exercise stress testing and inotrope infusion in chronic heart failure patients.
Topics: Aged; Chronic Disease; Dobutamine; Electrocardiography; Exercise Test; Heart Failure; Heart Rate; Humans; Middle Aged; Reproducibility of Results; Signal Processing, Computer-Assisted; Sympathomimetics | 1996 |
Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201Tl tomography versus dobutamine echocardiography.
Topics: Aged; Cell Survival; Chronic Disease; Circadian Rhythm; Coronary Disease; Dobutamine; Echocardiography; Follow-Up Studies; Heart; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Revascularization; Radionuclide Imaging; Rest; Systole; Thallium Radioisotopes; Time Factors; Ventricular Dysfunction, Left | 1996 |
Prostaglandin E1--bridge to cardiac transplantation. Technique, dosage, results.
Topics: Alprostadil; Cardiotonic Agents; Catheters, Indwelling; Chronic Disease; Disease Progression; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Safety; Treatment Outcome; Vasodilator Agents | 1997 |
Dobutamine stress-redistribution-reinjection versus rest-redistribution thallium-201 SPECT in the assessment of myocardial viability.
Topics: Adrenergic beta-Agonists; Blood Pressure; Chronic Disease; Coronary Angiography; Coronary Disease; Dobutamine; Echocardiography; Electrocardiography; Exercise Test; Female; Follow-Up Studies; Heart; Humans; Injections, Intravenous; Male; Middle Aged; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1997 |
Assessment of myocardial viability in patients with chronic coronary disease.
Topics: Cardiotonic Agents; Chronic Disease; Coronary Disease; Dobutamine; Echocardiography; Heart; Humans; Myocardial Contraction; Radionuclide Imaging; Thallium Radioisotopes | 1997 |
Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function.
Topics: Atrial Function, Left; Cardiotonic Agents; Chronic Disease; Dobutamine; Echocardiography, Doppler; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Mitral Valve; Nitroprusside; Pulmonary Wedge Pressure; Vasodilator Agents; Ventricular Function, Left | 1997 |
Relation of ultrasonic tissue characterization with integrated backscatter to contractile reserve in chronic left ventricular ischemic dysfunction.
Topics: Adult; Aged; Cardiotonic Agents; Case-Control Studies; Chronic Disease; Coronary Disease; Dobutamine; Echocardiography, Transesophageal; Female; Humans; Male; Middle Aged; Myocardial Contraction; Periodicity; Recruitment, Neurophysiological; Severity of Illness Index; Ventricular Dysfunction, Left | 1998 |
Evaluation of myocardial ischemia in Kawasaki disease by dobutamine stress signal-averaged ventricular late potentials.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Analysis of Variance; Child; Child, Preschool; Chronic Disease; Dobutamine; Electrocardiography; Female; Humans; Infant; Male; Mucocutaneous Lymph Node Syndrome; Myocardial Ischemia; Reproducibility of Results; Signal Processing, Computer-Assisted | 1997 |
Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: implications of time course of recovery on diagnostic accuracy.
Topics: Adult; Aged; Cardiotonic Agents; Chronic Disease; Coronary Disease; Dobutamine; Exercise Test; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Radionuclide Ventriculography; Time Factors; Treatment Outcome; Ultrasonography; Ventricular Dysfunction, Left | 1998 |
Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization.
Topics: Adult; Aged; Cardiotonic Agents; Chronic Disease; Coronary Angiography; Dobutamine; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Revascularization; Predictive Value of Tests; Prospective Studies; Treatment Outcome; Ventricular Dysfunction, Left | 1998 |
Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure.
Topics: Cardiotonic Agents; Chronic Disease; Coronary Artery Bypass; Coronary Disease; Dobutamine; Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Stunning; Patient Selection; Predictive Value of Tests; Regression Analysis; Tomography, Emission-Computed | 1998 |
Post-ejection thickening as a marker of viable myocardium. An echocardiographic study in patients with chronic coronary artery disease.
Topics: Adult; Angioplasty; Biomarkers; Cardiotonic Agents; Chronic Disease; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Dobutamine; Exercise Test; Female; Heart; Humans; Male; Middle Aged; Myocardial Contraction; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ultrasonography; Vasodilator Agents | 1998 |
Dobutamine stress echocardiography in the prediction of acute or chronic myocardial infarction.
Topics: Acute Disease; Aged; Cardiotonic Agents; Chronic Disease; Dobutamine; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prospective Studies; Ultrasonography | 1998 |
Dobutamine-atropine stress echocardiography for risk stratification in patients with chronic left ventricular dysfunction.
Topics: Adult; Aged; Atropine; Chronic Disease; Coronary Angiography; Disease-Free Survival; Dobutamine; Echocardiography; Exercise Test; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Parasympatholytics; Prognosis; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sympathomimetics; Ventricular Dysfunction, Left | 1999 |
Limited myocardial contractile reserve and chronotropic incompetence in patients with chronic Chagas' disease: assessment by dobutamine stress echocardiography.
Topics: Cardiotonic Agents; Chagas Cardiomyopathy; Chronic Disease; Dobutamine; Echocardiography; Exercise Test; Female; Follow-Up Studies; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Prognosis; Prospective Studies; Stimulation, Chemical; Ventricular Dysfunction, Left | 1999 |
Arrhythmic effects of intermittent dobutamine therapy in chronic heart disease failure. The Working Group of Cardiology of the Academic Committee of Veszprém, Hungary.
Topics: Adrenergic beta-Agonists; Adult; Aged; Arrhythmias, Cardiac; Chronic Disease; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged | 1998 |
[Pharmacological stress echocardiography--a new non-invasive follow-up examination of intermittent ventilation].
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Aged; Chronic Disease; Dobutamine; Echocardiography, Doppler; Exercise Test; Female; Follow-Up Studies; Hemodynamics; Humans; Intermittent Positive-Pressure Ventilation; Male; Middle Aged; Respiratory Insufficiency | 1999 |
Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography.
Topics: Aged; Cardiotonic Agents; Chronic Disease; Coronary Disease; Dobutamine; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; ROC Curve; Stroke Volume; Treatment Outcome; Ultrasonography; Ventricular Dysfunction, Left | 1999 |
Allograft vasculopathy: diagnosing the nemesis of heart transplantation.
Topics: Adrenergic beta-Agonists; Chronic Disease; Coronary Angiography; Coronary Disease; Diagnosis, Differential; Dobutamine; Echocardiography; Graft Rejection; Heart Transplantation; Humans; Transplantation, Homologous; Ultrasonography, Interventional | 1999 |
Quantification of 99Tcm-sestamibi and 123I-BMIPP uptake for predicting functional outcome in chronically ischaemic dysfunctional myocardium.
Topics: Aged; Angioplasty, Balloon, Coronary; Chronic Disease; Coronary Artery Bypass; Dobutamine; Echocardiography; Fatty Acids; Female; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Time Factors; Ventricular Dysfunction, Left | 1999 |
Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Chronic Disease; Coronary Disease; Dobutamine; Echocardiography; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Prognosis; Prospective Studies; Ventricular Dysfunction, Left | 1999 |
[Myocardial viability in man: state of the art and directions to pursue].
Topics: Cardiotonic Agents; Chronic Disease; Coronary Circulation; Dobutamine; Echocardiography; Forecasting; Heart; Humans; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Myocardium; Prognosis; Sensitivity and Specificity; Tissue Survival; Tomography, Emission-Computed; Ventricular Dysfunction, Left; Ventricular Function, Left | 1999 |
Myocardial viability detected by dobutamine echocardiography in patients with chronic coronary artery disease, and long-term outcome after coronary angioplasty.
Topics: Aged; Angioplasty, Balloon, Coronary; Chronic Disease; Coronary Disease; Dobutamine; Echocardiography; Female; Heart; Humans; Male; Middle Aged; Time Factors | 2000 |
Hemodynamic effects of a novel sodium channel activator in dogs with chronic heart failure.
Topics: Animals; Anti-Arrhythmia Agents; Cardiotonic Agents; Chronic Disease; Digoxin; Disease Models, Animal; Dobutamine; Dogs; Heart Failure; Hemodynamics; Sodium Channels; Sympathomimetics; Ventricular Function | 2000 |
Transpulmonary passage of Albunex as a marker of intracardiac hemodynamics and outcome in chronic congestive heart failure.
Topics: Adult; Aged; Albumins; Capillary Permeability; Cardiotonic Agents; Chronic Disease; Contrast Media; Dobutamine; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prognosis; Survival Rate; Treatment Outcome | 2000 |
Analysis of agreement between dobutamine stress echocardiography and exercise nuclear angiography in severe aortic regurgitation.
Topics: Aortic Valve Insufficiency; Blood Flow Velocity; Cardiotonic Agents; Chronic Disease; Coronary Disease; Dobutamine; Echocardiography, Doppler; Exercise Test; Female; Humans; Injections, Intravenous; Male; Middle Aged; Observer Variation; Prognosis; Radionuclide Angiography; Stroke Volume; Tin Polyphosphates | 2000 |
An experimental model of chronic myocardial hibernation.
Topics: Animals; Chronic Disease; Disease Models, Animal; Dobutamine; Echocardiography; Male; Myocardial Stunning; Myocardium; Swine; Swine, Miniature; Tissue Survival; Tomography, Emission-Computed | 2000 |
Head to head comparison of dobutamine-transoesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease.
Topics: Aged; Chronic Disease; Coronary Disease; Dobutamine; Echocardiography, Transesophageal; Humans; Magnetic Resonance Imaging; Middle Aged; Myocardial Revascularization; Postoperative Period; Prognosis; Prospective Studies; Recovery of Function; Stroke Volume; Ventricular Function, Left | 2000 |
Ultrasonic tissue characterization evaluates myocardial viability and ischemia in patients with coronary artery disease.
Topics: Cardiotonic Agents; Chronic Disease; Coronary Disease; Dobutamine; Echocardiography; Exercise Test; Female; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Myocardium; ROC Curve; Severity of Illness Index; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 2000 |
Prediction of contractile reserve by cyclic variation of integrated backscatter of the myocardium in patients with chronic left ventricular dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Chronic Disease; Dobutamine; Female; Heart Septum; Humans; Male; Middle Aged; Myocardial Contraction; Sensitivity and Specificity; Ultrasonography; Ventricular Dysfunction, Left | 2001 |
Evaluation of the response to pharmacological stress in chronic aortic regurgitation.
Topics: Adult; Aortic Valve Insufficiency; Chronic Disease; Dobutamine; Echocardiography; Exercise Test; Female; Follow-Up Studies; Humans; Male; Middle Aged; Stroke Volume; Ventricular Function, Left | 2001 |
Mechanism of myocardial dysfunction in the presence of chronic coronary stenosis and normal resting myocardial blood flow: clinical implications.
Topics: Animals; Chronic Disease; Coronary Circulation; Coronary Stenosis; Disease Models, Animal; Dobutamine; Dogs; Echocardiography; Endocardium; Hemodynamics; Myocardial Contraction; Myocardium; Radionuclide Imaging; Ventricular Dysfunction, Left | 2001 |
Biventricular systolic function in young lambs subject to chronic systemic right ventricular pressure overload.
Topics: Age Factors; Animals; Aorta; Blood Pressure; Cardiac Output; Cardiomegaly; Cardiotonic Agents; Chronic Disease; Dobutamine; Sheep; Systole; Ventricular Dysfunction, Right; Ventricular Function; Ventricular Pressure | 2001 |
Dobutamine stress echocardiography for the detection of myocardial viability in patients with left ventricular dysfunction taking beta blockers: accuracy and optimal dose.
Topics: Adrenergic beta-Antagonists; Atenolol; Cardiotonic Agents; Chronic Disease; Coronary Artery Bypass; Dobutamine; Dose-Response Relationship, Drug; Echocardiography, Stress; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Postoperative Care; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2002 |
Positive inotropic drug infusions for patients with heart failure: current controversies and best practice.
Topics: Cardiotonic Agents; Chronic Disease; Dobutamine; Dopamine; Female; Heart Failure; Hemodynamics; Home Infusion Therapy; Humans; Infusions, Intravenous; Male; Milrinone; Monitoring, Physiologic; Patient Selection; Prognosis; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2002 |
Use of cyclic variation of integrated backscatter to assess contractile reserve and myocardial viability in chronic ischemic left ventricular dysfunction.
Topics: Adult; Aged; Cardiotonic Agents; Chronic Disease; Dobutamine; Echocardiography, Stress; Female; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Revascularization; Predictive Value of Tests; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2002 |
Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure.
Topics: Chronic Disease; Dobutamine; Dopamine; Heart; Heart Failure; Hemodynamics; Humans; Hydralazine; Monitoring, Physiologic; Nitrates; Nitroprusside; Phentolamine; Prazosin; Teprotide; Vasodilator Agents | 1979 |
Antagonism of chronic canine beta-adrenergic blockade with dopamine-isoproterenol, dobutamine, and glucagon.
Topics: Animals; Cardiac Output; Catecholamines; Chronic Disease; Dobutamine; Dogs; Dopamine; Glucagon; Hemodynamics; Isoproterenol; Propranolol | 1979 |
Comparative responses to dobutamine and nitroprusside in patients with chronic low output cardiac failure.
Topics: Adult; Aged; Arterioles; Blood Pressure; Cardiac Output; Cardiomyopathies; Catecholamines; Chronic Disease; Coronary Disease; Dobutamine; Ferricyanides; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Nitroprusside; Oxygen; Pulmonary Artery | 1977 |
Influence of dobutamine on regional myocardial blood flow and ventricular performance during acute and chronic myocardial ischemia in dogs.
Topics: Acute Disease; Animals; Blood Pressure; Catecholamines; Chronic Disease; Coronary Circulation; Coronary Disease; Coronary Vessels; Dobutamine; Dogs; Heart; Heart Rate; Myocardial Contraction; Myocardial Infarction; Pressure; Propranolol | 1976 |
Relationship among neuropeptide Y, catecholamines and haemodynamics in congestive heart failure.
Topics: Adult; Cardiac Output; Cardiomyopathy, Dilated; Chronic Disease; Coronary Vessels; Dobutamine; Dose-Response Relationship, Drug; Epinephrine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neuropeptide Y; Norepinephrine; Sympathetic Nervous System | 1992 |
Effects of cardiovascular drugs on oxygen consumption/oxygen delivery relationship in patients with congestive heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Catheterization, Swan-Ganz; Chronic Disease; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Oxygen Consumption; Phosphodiesterase Inhibitors; Pulmonary Edema | 1992 |
[The accuracy of echocardiography during the infusion of low-dose dobutamine in identifying vital myocardium in patients with obstructive coronary disease and chronic left ventricular dysfunction].
Topics: Adult; Aged; Chronic Disease; Coronary Angiography; Coronary Disease; Dobutamine; Echocardiography; Echocardiography, Doppler; Humans; Infusions, Intravenous; Intraoperative Care; Male; Middle Aged; Sensitivity and Specificity; Ventricular Function, Left | 1992 |
An animal model of chronic coronary stenosis resulting in hibernating myocardium.
Topics: Animals; Chronic Disease; Constriction, Pathologic; Coronary Circulation; Coronary Disease; Dobutamine; Female; Heart; Male; Mitochondria, Heart; Myocardium; Swine | 1992 |
Acute effects of beta-adrenergic stimulation with dobutamine on the plasma levels of atrial natriuretic peptide and cyclic guanosine monophosphate in patients with chronic heart failure.
Topics: Aged; Atrial Natriuretic Factor; Cardiomyopathy, Dilated; Chronic Disease; Cyclic GMP; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1991 |
Could glucose-insulin-potassium be considered only a step of a complete nutritional program for complicated cardiac patients?
Topics: Cardiopulmonary Bypass; Chronic Disease; Dobutamine; Glucose; Heart Failure; Humans; Insulin; Parenteral Nutrition; Potassium | 1991 |
Dobutamine stress testing in chronic heart failure--dose-response effects assessed by echo-Doppler.
Topics: Aged; Chronic Disease; Dobutamine; Drug Administration Schedule; Echocardiography, Doppler; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1991 |
Physical and pharmacological conditioning in chronic heart failure: a proposal for pulsed inotrope therapy.
Topics: Chronic Disease; Dobutamine; Drug Administration Schedule; Exercise Therapy; Heart Failure; Humans | 1991 |
Intermittent dobutamine infusion in severe chronic heart failure in elderly patients.
Topics: Aged; Chronic Disease; Clinical Protocols; Dobutamine; Drug Administration Schedule; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male | 1990 |
Chronic therapy of severe heart failure with enoximone.
Topics: Aged; Cardiotonic Agents; Chronic Disease; Dobutamine; Enoximone; Female; Heart Failure; Humans; Imidazoles; Male; Middle Aged | 1989 |
[Dobutamine infusion test for predicting the postoperative recovery of left ventricular function in patients with chronic aortic regurgitation].
Topics: Aortic Valve; Aortic Valve Insufficiency; Chronic Disease; Dobutamine; Echocardiography; Heart; Heart Valve Prosthesis; Heart Ventricles; Humans; Postoperative Period | 1989 |
Do positive inotropic agents adversely affect the survival of patients with chronic congestive heart failure? III. Antagonist's viewpoint.
Topics: Adrenergic beta-Agonists; Animals; Cardiotonic Agents; Chronic Disease; Death, Sudden; Dobutamine; Heart Failure; Humans; Milrinone; Phosphodiesterase Inhibitors; Pyridones | 1988 |
Dobutamine rescue for intractable CHF.
Topics: Chronic Disease; Dobutamine; Heart Failure; Humans; Infusions, Intravenous; Monitoring, Physiologic | 1988 |
[Evaluation of left ventricular function in patients with chronic aortic regurgitation using dobutamine infusion test: predict early postoperative left ventricular function].
Topics: Adult; Aged; Aortic Valve Insufficiency; Chronic Disease; Dobutamine; Female; Heart; Heart Function Tests; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Postoperative Period; Predictive Value of Tests | 1987 |
Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patients.
Topics: Adult; Aged; Ambulatory Care; Cardiac Output; Chronic Disease; Dobutamine; Dopamine; Equipment Failure; Female; Heart Failure; Humans; Infusion Pumps; Infusions, Intravenous; Male; Middle Aged; Stroke Volume | 1987 |
Chronic congestive heart failure. Where have we been? Where are we heading?
Topics: Aminopyridines; Amrinone; Biopsy; Calcium Channel Blockers; Cardiology; Chronic Disease; Digitalis; Dobutamine; Dopamine; Forecasting; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Myocardial Contraction; Myocardium; Plants, Medicinal; Plants, Toxic; Prognosis; Quality of Life; Vasodilator Agents | 1986 |